News

Investigators studied patients from 5 unrelated families to determine the genetic mutations causing the condition.

Despite previous observations that high-quality diet correlates to lower depression symptoms, new results paint a different picture.

Studies show that more than 90% of EoE patients improve symptoms with food elimination therapy. Should more patients be in touch with allergists?

In a rare clinical trial, stem cell transplantation appeared to provide greater protection against MS progression than DMT.

A prospective study of over 500 patients found those with influenza A had more severe symptoms and slower recovery than those with influenza B.

This is the third indication for the biologic therapy, following its approvals for adult AD and moderate to severe asthma maintenance care.

An FDA decision on the application is expected by December 27, 2019.

If approved by the FDA later this year, the Allergan drug would become the first oral CGRP receptor antagonist approved for acute migraine treatment.

Researchers calculate universal HCV screening of pregnant women would be cost-effective in the US, including in states with low HCV prevalence.

One of the pioneer investigators of ketamine for depression explains what its recent approval for a severe form of the condition means for patients running out of options.

Research into a rare neurological disorder may help researchers working on more common diseases including autism and epilepsy.

The supplemental BLAs seek to expand onabotulinumtoxinA label to treat pediatric patients with upper and lower limb spasticity.

The Genentech therapy is currently the first and only single-dose oral medicine marketed for flu treatment, and was the first new flu medicine with a novel mechanism of action in 2 decades.

A new report shows that multiple sclerosis diagnoses have steadily risen in older patients in the past 5 years, bucking previous patient rate estimates.

Both entrectinib and polatuzumab vedotin target hard-to-treat cancers.

Researchers say a new challenge virus didn’t lead to influenza in as many patients as expected, but it will still yield valuable insights as researchers push to develop a universal flu vaccine.

Confocal microscopy is especially useful for diagnosing pigmented lesions, moles, melanoma, and basal cell carcinoma.

The therapy becomes the first novel mechanism of action-driven drug approved for depression in 30 years.

The 23rd FDA commissioner's tenure lasted less than 2 years, since May 2017.

Galcanezumab was previously given a Breakthrough Therapy Designation for this indication.

According to investigators, recent trial results indicate no other biologic treatment has shown as rapid onset than benralizumab for patients with eosinophilic asthma.

The CNS stimulant was approved as an extended-released capsule intended to serve as a first-line ADHD therapy.

Analysis of multiple studies demonstrates glecaprevir/pibrentasvir pangenotypic HCV efficacy despite concurrent gastric acid-reducing drugs.

A study suggests individuals who received egg-based flu vaccines had less protection against circulating strains of influenza than those with cell-based vaccines in the 2017-2018 season.

By identifying epitopes that are common to all types of the flu, researchers believe they may have created a pathway to a universal flu vaccine.

The 100 Units/mL/ 300 mcg/mL-dosed therapy was previously approved as an add-on therapy to diet and exercise in adults with T2D.

The new guideline centers on the overall diagnosis, management, and clinical treatment of the chronic inflammatory disease.

There has been a debate about whether retina specialists under-treat with anti-VEGF therapy in the real-world setting.